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Abstract
Adenovirus (Ad) serotype 5 (Ad5) fiber competitively binds to the coxsackievirus and Ad receptor (CAR) to attach Ad5 to
target cells and also disrupts cell junctions and facilitates virus escape at a late stage in Ad5 infection. Here we demonstrate
that paracellular permeability in MCF7 and CAR overexpressing MCF7 (FLCARMCF7) cells is increased within minutes
following the addition of Ad5 to cells. This is brought about, at least in part, by altering the molecular dynamics of E-
cadherin, a key component of the cell-cell adhesion complex. We also demonstrate that the increase in E-cadherin mobility
is constitutively altered by the presence of CAR at FLCARMCF7 cell junctions. As increased paracellular permeability was
observed early after the addition of Ad5 to cells, we postulate that this may represent a mechanism by which Ad5 could
disrupt cell junctions to facilitate further access to its cell receptors.
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Introduction
Most Adenovirus (Ad) species attach to host cells through the
interaction of the fiber protein with the Coxsackievirus and
Adenovirus (Ad) receptor (CAR) [1,2,3,4]. CAR is a transmem-
brane protein that is predominantly localised to the baso-lateral
surface of polarised epithelium and at tight junctions where it
binds to multiple proteins including zonula occludens (ZO-1), b-
catenin [5,6,7,8], actin [9] and tubulin [10]. CAR is one of a
number of immunoglobulin-like molecules at cell junctions. These
include junctional adhesion molecules (JAM)-A, B & C
[11,12,13,14]; endothelial cell-selective adhesion molecule
(ESAM) [15]; and JAM4 [16]. As a component of cell junctions,
CAR may mediate cell adhesion by virtue of homophilic
interaction between CAR molecules on adjacent cells. Interest-
ingly, Ad serotype 5 (Ad5) fiber protein binds to CAR with higher
affinity than CAR does for itself [17] suggesting that Ad5 may
weaken cell junctions by disrupting CAR interaction between
adjacent cells. Ad5 exploits its ability to competitively bind to CAR
to disrupt junctions to escape infected cells and further propagate
infection [18]. This is brought about by excess fiber, produced at
the late stage of Ad5 infectious cycle. This disruption in cell
junctions was shown to coincide with re-localisation of -catenin,
which in fact co-immunoprecipitates with CAR not only in A549
[18] but also Sertoli cells [19]. This led to the suggestion that Ad5
disruption of cell junctions at the late stages of its infectious cycle is
independent of E-cadherin. E-cadherin is however a key
component of the cell adhesion complex [20,21] where it
promotes cell-cell contact through homophilic binding to E-
cadherin molecules on adjacent cell junctions supported by actin
filaments through b- and a-catenins [22,23,24,25]. It is generally
accepted that E-cadherin is highly mobile at immature and
developing cell contacts, but in mature junctions, the mobile pool
of E-cadherins is in the minority [22,23]. For example, in new
areas of cell contact, E-cadherin pool is mainly composed of a
highly mobile fraction (90%). Once E-cadherin clusters are formed
and E-cadherin begins to interact with the cytoskeleton, a much
smaller fraction (50%) remains mobile. At mature junctions, the
mobile fraction is even smaller (,10%) [22,23]. The mobile E-
cadherin population is monomeric; it diffuses on the membrane,
exchanges with the stable E-cadherin population at contact sites
and is not involved in cell adhesion [26]. Regulation of E-cadherin
levels in developing and mature junctions is a dynamic process
that is not fully understood. Recent evidence suggests that
recycling of E-cadherin at cell junctions involves exchange
between membrane and intracellular pools of E-cadherin, a
process linked to endocytosis [27].
As Ad5 binds to CAR with similar affinity as does soluble Ad5
fiber [4], we hypothesised that intact Ad5 virion may disrupt cell
junctions and alter paracellular permeability at an early stage in its
infectious cycle, not just at late stages, as it was previously shown.
We addressed this question in MCF7 cells that are a human breast
tumour-derived cell line and had been extensively used to
investigate the regulation of cell junctions and more specifically
E-cadherin dynamics during junction formation and disruption
[27,28,29,30]. Moreover, we have already shown that MCF7 cells
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mediates Ad5 internalisation and are infectable by Ad5 [31]. We
have also shown that CAR-RFP when expressed on the cell
surface of FLCARMCF7 cells localises at cell junctions and
efficiently facilitates Ad5 infection [31]. In the same study, we also
showed no difference in proliferation rate between MCF7 and
FLCARMCF7 cells and went on to demonstrate that signalling
downstream of CAR can have effects on integrins and CAR itself
to promote Ad5eGFP binding [31].
Our experiments demonstrate that high viral loads of Ad5GFP
(Ad5eGFP is an E1–E3-deleted Ad5 that expresses green
fluorescent protein (GFP) as a transgene under the control of the
cytomegalovirus promoter) increased paracellular permeability in
MCF7 and CAR over-expressing MCF7 cell junctions. We also
demonstrate enhanced E-cadherin molecular dynamics in the
presence of Ad5GFP, a process that appeared to be modulated by
CAR.
Results
High CAR expression leads to reduced E-cadherin at cell-
cell junction
Junctional membrane proteins and E-cadherin in particular
play a key role in cell-cell junction formation and stability. As
CAR is a transmembrane cell-cell junction, protein we assessed the
effect of its over expression on other junctional membrane
proteins. We therefore compared endogenous levels of E-cadherin,
b-catenin, a-catenin and ZO-1 between MCF7 cells and MCF7
cells stably expressing functional full-length human CAR C-
terminally tagged with monomeric red fluorescent protein
(FLCARRFP; FLCARMCF7 cells) [31] to determine if endoge-
nous levels of these proteins were affected by the over-expressed
CAR. We had previously reported that FLCARRFP is efficiently
recruited to junctions in MCF7 cells [31] (Supplementary Figure
S1). Figure 1 shows that expression levels of b-catenin, a-catenin
and ZO-1 were equal between MCF7 and FLCARMCF7 cells
(Figure 1A). To then assess if the localisation of these proteins was
altered by the over-expression of CAR, confocal images were also
taken of a 1:1 mixed population of MCF7 and FLCARMCF7
cells. Images in Figure 1B demonstrate that a-catenin, b-catenin
and ZO-1 localise similarly to FLCARMCF7 and MCF7 cell
junctions. In contrast, the level of E-cadherin present at CAR
positive FLCARMCF7 cell junctions appeared to be consistently
lower compared to MCF7 cell junctions (Figure 1B). To evaluate
this further, intensity line scans were taken across individual
junctions highlighted in Figure 1B and the relative levels of CAR
and E-cadherin assessed using ImageJ and intensity profiles plotted
over distance. Intensity levels of E-cadherin at junctions between
multiple FLCARRFP positive cells, or those without FLCARRFP
was then quantified and shown to be significantly greater in MCF7
compared to FLCARMCF7 cell junctions (Figure 1C). This data
indicates that E-cadherin localisation to cell junctions is reduced in
the presence of overexpressed CAR.
In order to obtain independent confirmation that CAR over
expression was associated with reduced E-cadherin in
FLCARMCF7 cells, a cell-binding assay was then conducted to
assess the level of binding of FLCARMCF7 cells to immobilised
purified extracellular domain of E-cadherin. Figure 2A shows
significantly higher binding of MCF7 cells to the E-cadherin
extracellular domain compared to FLCARMCF7 cells. To further
confirm these findings, we used FACS to analyse cell surface levels
of E-cadherin in both cell lines. Figure 2B demonstrates a
significant reduction in cell surface levels of E-cadherin in
FLCARMCF7 compared to parental cells. Taken together, data
based on microscopy experiments, cell binding assays and FACS
analysis, suggest that high levels of CAR can alter E-cadherin cell
surface levels on FLCARMCF7 cells and at FLACRMCF7 cell-
cell junctions.
Paracellular permeability is increased in the presence of
Ad5
Since CAR expression reduced E-cadherin cell surface levels
and also E-cadherin levels at FLCARMCF7 cell junctions, we
asked whether this had an effect on paracellular permeability. We
found no difference in basal permeability between MCF7 and
FLCARMCF7 cells (Figure 3). This suggests that the reduced E-
cadherin level at FLCARMCF7 cell junctions had no functional
consequence on the integrity of cell-cell contacts. One possible
explanation for this observations is that CAR-CAR interactions
contributes to the maintenance of cell-cell junctions in
FLCARMCF7 cells and thus compensates for the reduced E-
cadherin levels in these cells. We also found that the addition of
Ad5eGFP increased paracellular permeability in MCF7 and
FLCARMCF7 cells (Figure 3) and that this increase was more
pronounced in FLCARMCF7 cells than the parental cells. As
Ad5eGFP is replication deficient, disruption of cell junctions is
likely to be a function of the intact Ad5eGFP virion and not a
consequence of excess soluble fiber produced after virus
replication, at a late stage in the virus life cycle.
E-cadherin de-stabilises at cell-cell junctions in the
presence of Ad5eGFP
We then analysed the effect of Ad5eGFP on E-cadherin
mobility by determining the GFP tagged E-cadherin (E-
cadherin-GFP) fluorescence recovery after photobleaching (FRAP)
MCF7 and FLCARMCF7 cell junctions. Increased ability of E-
cadherin to move at junctions would be reflected by an increase in
FRAP [22]. MCF7 and FLCARMCF7 cells were transiently
transfected with E-cadherin-GFP and the rate of recovery of this
protein was examined every 15 seconds post bleach for 5 minutes
(Figure 4A). Under steady state conditions, the half-life (t1/2) of
recovery, which measures the rate of E-cadherin recovery
(Figure 4B), and the mobile and immobile E-cadherin fractions,
which measures the amount of fluorescent E-cadherin present in
the bleach region at the end of the experiment (Figure 4C), were
similar in MCF7 and FLCARMCF7 cells. The immobile E-
cadherin fraction was in the majority in both cell types (Figure 4C).
E-cadherin maximal percentage recovery was essentially the same
as the percentage recovery of the E-cadherin mobile fraction
(Figure 4C). In MCF7 cells the presence of Ad5eGFP increased
the half-life of E-cadherin recovery indicating that Ad5eGFP leads
to a reduction in the speed of recruitment of E-cadherin molecules
to MCF7 cell junctions. Ad5eGFP also increased the proportion of
E-cadherin in the mobile fraction, indicating an increase in the
mobility of E-cadherin. This demonstrates that Ad5eGFP leads to
both increased translocation of E-cadherin away from, and
decreased rate of E-cadherin recruitment to MCF7 cell junctions.
This could result in a net reduction in E-cadherin at MCF7 cell
junctions. In support of this, FACS analysis showed that Ad5eGFP
significantly reduced E-cadherin cell surface levels in MCF7 cells
(Figure 4D). The presence of FLCARRFP in FLCARMCF7 cell
junctions did not alter the E-cadherin mobility in the absence of
Ad5eGFP. However, the addition of Ad5eGFP to FLCARMCF7
cells led to more immobile E-cadherin being maintained at
FLCARRFP containing cell junctions compared to MCF7 cell
junctions (Figure 4C). This suggests that the Ad5eGFP-driven
increase in E-cadherin mobility is reduced in the presence of
Adenovirus Disrupts E-Cadherin Interactions
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we observed slower rates of E-cadherin recovery in the presence of
Ad5eGFP, although this rate of recovery was faster in these
compared to MCF7 cells (Figure 4C). This would indicate that in
cell junctions where CAR is overexpressed, the addition of
Ad5eGFP results in faster turnover of E-cadherin to these
junctions, where it is more likely that it will be retained as
immobile fraction. This is further supported by data demonstrat-
ing that Ad5eGFP did not induce changes in surface levels of E-
cadherin in FLCARMCF7 cells (Figure 4D). Taken together these
data suggest that Ad5eGFP reduced E-cadherin localisation to cell
junctions by modulating the dynamics of E-cadherin recruitment
to junctions, and that overexpression of CAR disrupts this.
We next applied similar approaches to determine whether
Ad5eGFP altered CAR levels and localisation. FACS and imaging
data demonstrated no difference in CAR levels at FLCARMCF7
cell junctions in the presence of Ad5eGFP (performed in separate
experiment; data not shown). Similarly, FRAP analysis to define
the molecular dynamics of CAR at FLCARMCF7 cell junctions
demonstrated no significant change in the rate of CAR recovery in
the presence or absence of Ad5eGFP (data not shown). This would
suggest that Ad5eGFP has little or no influence in the localisation
and mobility of CAR at FLCARMCF7 cell junctions.
E-cadherin/b-catenin complex is unaffected by over-
expression of CAR or Ad5eGFP in MCF7 cells
Maintenance of E-cadherin at cell junctions is partly controlled
by interaction of its cytoplasmic domain with b-catenin [24,25].
Therefore we investigated whether the localisation of the E-
cadherin/b-catenin complex was affected by the over-expression
of CAR or addition of Ad5eGFP. First, a mixed population of
MCF7 and FLCARMCF7 cells were incubated with Ad5eGFP for
3 and 10 minutes at 37uC. These time points coincide with Ad5
cell attachment and internalisation [32]. Images in Figure 5A show
expression and co-localisation of both E-cadherin and b-catenin at
the cell junctions of MCF7 and FLCARMCF7 cells. E-cadherin
and b-catenin localisation appeared unaffected by incubation with
Ad5eGFP at 3 minutes or 10 minutes (Figure 5). The intensity of
E-cadherin (Figure 5A) and b-catenin (data not shown) at MCF7
and FLCARMCF7 cell junctions was also unaffected by
incubation with Ad5eGFP. In order to confirm that Ad5eGFP
bound to MCF7 and FLCARMCF7 cells, Ad5eGFP-Cy5
(Ad5eGFP labelled with fluorescent dye Cy5) was added for three
minutes to coverslips that had been seeded with mixed population
of MCF7 and FLCARMCF7 cells (1:1 ratio) followed by fixation
with 4% PFA. Figure 5B shows Ad5eGFP-Cy5 bound to MCF7
(identified by their lack of RFP expression) and FLCARMCF7
cells. Binding was more clearly visible in FLCARMCF7 cells, in
keeping with their high CAR expression.
We then assessed the level of the E-cadherin/b-catenin complex
in MCF7 and FLCARMCF7 cells to determine whether over-
expression of CAR affected the formation of the complex.
Figure 5C shows that E-cadherin is complexed with b-catenin
and level of the complex is unchanged between the two cell types.
This indicates that the over-expression of CAR does not affect the
basal level of the E-cadherin/b-catenin complex. Moreover,
addition of Ad5eGFP or bacterial expressed recombinant Ad5
fiber knob domain (FK) did not significantly alter the level of E-
cadherin or b-catenin within the complex.
CAR associates with the b-catenin complex
Previous studies demonstrated co-immunoprecipitation of b-
catenin and CAR in A549 [18] and Sertoli cells [19]. Therefore,
we sought to examine whether CAR also associates with b-catenin
in FLCARMCF7 cells and whether such an association was
affected by incubation with Ad5eGFP. Figure 5D shows that CAR
co-immunoprecipitated with b-catenin, providing further evidence
of direct or indirect interaction between CAR and b-catenin.
Interestingly, incubation with Ad5eGFP increased the level of
CAR associated with b-catenin up to 6 hours post infection
(Figure 5D). Additionally, incubation with FK also increased the
level of CAR associated with b-catenin (Figure 5D). For cells
treated with Ad5eGFP, a significant difference was observed as
early as three minutes post infection. One possible explanation for
this observation is that binding of Ad5eGFP or FK to CAR
induces CAR clustering and therefore increased association with
b-catenin. Alternatively, the presence of Ad5eGFP or FK may
increase CAR affinity for b-catenin or another as yet unidentified
component of the complex. No association between CAR and b-
catenin was seen in MCF7 cells, probably due to the very low
endogenous levels of CAR found in these cells.
Discussion
In the present study we demonstrate that Ad5eGFP increased
paracellular permeability of MCF7 cells and CAR overexpressing
MCF7 cells. This was independent of Ad5 replication as
Ad5eGFP used in these experiments is replication deficient.
Moreover, as these changes were observed early after the
addition of Ad5eGFP to cells, we postulate that Ad5eGFP may
disrupt cell junctions at an early stage of its infectious cycle,
during virus binding and internalisation. This is consistent with
previous studies showing Ad5 fibre-mediated increase in para-
cellular permeability of bronchial epithelium [18]. This could
potentially provide a mechanism by which Ad5 can aid access to
its own receptor (CAR) and therefore facilitate cell entry. As these
experiments were performed in the presence of large excess of
recombinant virus particles in non-polarised epithelial cells the
significance of our observations in naturally occurring Ad5
infection cannot be determined. Interestingly however, loss of
airway epithelial integrity by means of antibody-mediated
disruption of E-cadherin function was shown to facilitate Ad
infection, presumably by improved accessibility of CAR to
incoming virus [33].
Figure 1. CAR reduces E-cadherin expression at CAR-expressing MCF7 cell junctions. (A) MCF7 parental (2) or FLCARMCF7 (+) cell lysates
subjected to western blot analysis for total a-catenin, b-catenin, E-cadherin and ZO-1 protein levels. Actin serves as a loading control. There was no
difference in the level of expression of these proteins in the presence/absence of CAR. (B) Confocal images of MCF7 and FLCARMCF7 (red channel)
cells immunostained for a-catenin, b-catenin, E-cadherin and ZO-1 antibodies labelled with Oregon green. The levels and localisation of a-catenin,
b-catenin and ZO1 appeared the same in MCF7 and FLCARMCF7 cells but E-cadherin expression was reduced in CAR expressing junctions (denoted
by white arrows and highlighted in the inset). These are representative images from at least 3 experiments, with reduced E-cadherin being evident in
more than 80% of CAR expressing junctions. (C) Bar charts are quantitations of E-cadherin or b-catenin intensity at junctions between FLCARRFP
positive cells (FLCARMCF7), or those without CAR (MCF7) and calibrated on a per pixel basis to correct for any differences in junction size/area. MCF7
junction intensity values were normalised to 1 and all values for FLCARMCF7 junctions represented as a relative value to this. Values were pooled
from multiple cells and images (n=.25 junctions per condition) over three independent experiments and represented as relative mean intensity
*P ,0.05. Significance was determined by a two-way anova.
doi:10.1371/journal.pone.0023056.g001
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was immobilised onto 24-well plates at 1.5 mg/ml or 5 mg/ml. BSA was used as a control. MCF7 (black bars) or FLCARMCF7 cells (white bars) were
seeded at 5610
4/well, left for 2 hours, and adherent cells counted. Error bars depict SEM (n=4). ** p,0.01. (B) FACS analysis of E-cadherin cell-
surface expression on MCF7 (black bar) and FLCARMCF7 cells (white bar). MFI per cell pooled from 4 independent experiments is shown +/2SEM.
*P ,0.05. Significance was determined by a two-way anova.
doi:10.1371/journal.pone.0023056.g002
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MCF7 and FLCARMCF7 cells altered the molecular dynamics of
E-cadherin. We assessed the dynamics of E-cadherin by measuring
the rate of recovery of E-cadherin and the amount of fluorescent
E-cadherin present after photobleaching MCF7 and
FLCARMCF7 cell junction in the presence or absence of
Ad5eGFP. It is important to note that these two measurements
are not directly coupled and do not necessarily correlate.
Regulation of E-cadherin levels at mature as well as immature
cell junctions is a dynamic process. In immature and developing
junctions mobile E-cadherin fraction is more abundant compared
to mature cell junctions where the immobile fraction is in the
majority [26,27]. The mobile E- cadherin diffuses on the
membrane and exchanges with the stable E-cadherin population
at contact sites [26]. In Drosophila, a dynamic actin population
controls E-cadherin movement across the membrane, whereas a
separate population of actin molecules anchors and stabilises E-
cadherin at points of cell contact [26]. Even in mature junctions
there is considerable E-cadherin recycling between membrane and
intracellular E-cadherin pools, a process dependent on vesicle
trafficking and endocytosis [27]. It is interesting to note that
changes in the half-life of E-cadherin recovery of the order
observed in our studies have been correlated with cell migration in
vitro [34].
Our observation that Ad5eGFP increased the mobile E-
cadherin fraction and reduced cell surface E-cadherin levels in
MCF7 cells indicates that in the absence of high CAR levels, less
E-cadherin is stably associated with the cytoskeleton than in CAR
overexpressing FLCARMCF7 cells junctions. Ad5eGFP also
reduced the rate of E-cadherin recovery in MCF7 compared to
FLCARMCF7 cells junctions, which suggests that E-cadherin
recycling and movement occurs over a slower time period in the
presence of CAR. The fact that Ad5eGFP increased paracellular
permeability at MCF7 cell junctions may have been a conse-
quence of the altered E-cadherin molecular dynamics in the
presence of Ad5eGFP. Alternatively, the increased mobile E-
cadherin fraction in the presence of Ad5eGFP could be secondary
to disruption of cell junctions brought about by other means.
Further studies are required to resolve these questions.
In FLCARMCF7 cell junctions we observed slower rates of E-
cadherin recovery in the presence of Ad5eGFP, although this rate
of recovery was faster in these compared to MCF7 cells.
Interestingly, we also found that in the presence of Ad5eGFP,
the mobile E-cadherin fraction was smaller and the immobile
fraction larger in FLCARMCF7 than MCF7 cells. This would
indicate that in the presence of high CAR levels (as in
FLCARMCF7 cells) and Ad5eGFP, there is a shift towards more
rapid turnover of E-cadherin to junctions, perhaps from a free
cytoplasmic pool, with more E-cadherin being retained at
FLCARMCF7 junctions as immobile fraction than in MCF7
cells, where CAR is expressed at low levels. These observations
may help us understand why Ad5eGFP increased paracellular
permeability to a greater extent in FLCAR than the parental
MCF7 cells. It has already been shown that recombinant Ad fiber
knob applied directly to the basolateral surface of well-differen-
tiated airway epithelial cells can disrupt junctional complexes and
increase paracellular permeability, probably by disrupting CAR-
CAR homotypic interactions [18]. We therefore postulate that
competitive inhibition of the CAR-CAR homophilic interaction in
FLCARMCF7 cells by Ad5eGFP and its consequent disruption of
CAR junctional complexes might account for this increased
permeability and that changes in E-cadherin dynamics are in
response to this. We speculate that CAR, when over expressed,
may partially replace E-cadherin at junctions and in doing so alter
the kinetics of E-cadherin recovery when cell junctions are
disrupted. It is interesting therefore that we also observed that in
Figure 3. Ad5eGFP increases paracellular permeability. Paracellular permeability was assessed across MCF7 and FLCARMCF7 either basally
and in response to Ad5eGFP (9000 VP/cell) added either simultaneously or 2 hours prior to incubation with FITC-dextran (1 mg/ml). No difference in
basal permeability was seen between MCF7 and FLCARMCF7 cells. Incubation with Ad5eGFP led to increased permeability in MCF7 and FLCARMCF7
cells and this increase was more pronounced in FLCARMCF7 cells. ***=p,0.001, **=p,0.01, *=p,0.05.
doi:10.1371/journal.pone.0023056.g003
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cadherin expression at FLCARMCF7 cell junctions. As reduced
E-cadherin levels occurred without any changes to either the level
or localisation of ZO-1, b-catenin or a-catenin it is unlikely that
this is due to non-specific consequence of CAR over-expression.
This conclusion is supported by recent studies that showed CAR
expression in lung cancer cells was associated with absence of E-
cadherin [35]. Such loss of E-cadherin at cell junctions did not
alter paracellular permeability suggesting that CAR can compen-
sate for E-cadherin in maintaining junctional integrity. Therefore,
high levels of CAR may alter cell junction protein composition but
not its integrity. This would be in keeping with previous studies
that showed that CAR is required for initiation and maintenance
of airway epithelial cell barrier and that CAR expression reduced
paracellular permeability [36].
Our immunoprecipitation experiments showed increased associ-
ation of CAR with b-catenin in the presence of Ad5eGFP. As
recombinant Ad5 fiber knob had the same effect on the complex as
Ad5eGFP, it is likely that the increased association with b-catenin is
brought aboutbyCARinteracting with itsAd5ligand.Onepossible
explanation for this observation is that binding of free FK or intact
Ad5eGFP to the CAR extracellular domain promotes clustering of
CAR and b-catenin so that they can interact. However, CAR
clustering isthought to be a consequenceofAd5butnot FK binding
to CAR. Indeed we have shown that Ad5 but not FK induces p44/
42 dependent CAR dimerisation in cis in MCF7 cells [31]. An
alternative explanation for our observations would be that
Ad5eGFP or FK binding to CAR increases affinity of CAR for b-
catenin. This raises the possibility that ligand-induced increased
association of CAR with b-catenin could displace E-cadherin from
the E-cadherin/b-catenin complex. It is interesting that it was
previously suggested that CAR and E-cadherin do not directly
interact and that CAR and E-cadherin may in fact compete for the
same binding site on b-catenin [18]. The fact that E-cadherin/b-
catenin complex level was the same in MCF7 and FLCARMCF7
cells basally and in response to Ad5eGFP would however suggest
that it is unlikely that CAR and E-cadherin compete for binding to
b-catenin in FLCARMCF7 cells. Our experiments do not exclude
the possibility that CAR and E-cadherin interact directly. However,
we have not consistently shown direct biochemical interaction
between CAR and E-cadherin (data not shown) which would
suggest that CAR and E-cadherin may not directly interact, or that
they do so transiently thus not allowing detection of such interaction
biochemically.
The mechanism by which CAR modulates E-cadherin basally
and in response to Ad5 was not addressed in this study. Further
studies are necessary to investigate this question. It is interesting in
this context that JAM-A, a junctional molecule with which CAR
shares homology, appears to negatively regulate E-cadherin levels
in hepatocytes [37].
Our observation that CAR can modulate E-cadherin has
broader implications beyond its potential role in Ad5 infection.
This and the fact that CAR is a component of tight junctions raise
the possibility that CAR contributes to the maintenance of
epithelial cell junctions. Cell junctions are dynamic structures that
assemble, break down and reassemble in response to a wide range
of triggers such as cell division, cell migration, infection or
inflammation. Understanding how CAR and E-cadherin interact
at tight junctions will provide further insight on the pathways
involved in the dynamics of cell junction formation and disruption.
Methods
Cells and materials
MCF7 (human breast cancer cells) were obtained from ATCC
(ATCC number HTB-22
TM) and were maintained in Dulbecco’s
modified Eagle’s medium (Gibco) supplemented with 10% fetal
bovine serum (FCS, Sigma). MCF7 cells were transfected with
plasmids containing FLCAR and cell clones (FLCARMCF7) were
selected in the presence of geneticin (Gibco), as previously
described [31]. Ad5eGFP was obtained from Vector Development
Laboratory, Baylor College of Medicine, USA. 9000 virus particles
(VP)/cell were used in all experiments. Ad5eGFP-Cy5 was
Ad5eGFP labelled with Cy-5, a fluorescent dye producing a
signal in the far-red region of the spectrum (670 nm). Ad5eGFP
was mixed with 1 M NaHCO3 was added to one vial of Cy-5 and
incubated for 30 minutes in the dark. The reaction was then
terminated by the addition of 0.5 ml of 0.5 M Tris (pH 8). Excess
dye was removed by dialysis using small dialysis cassettes (Pierce,
02203 ml) cassettes. Recombinant FK was produced and purified
as previously described [3,4,38]. MCF7 and FLCARMCF7 cells
were transiently transfected with E-cadherin GFP (gift of Dr Mark
May University of Michigan).
Generation of CAR constructs
FLCAR was amplified by PCR using the GCGCAAGCT-
TATGGCGCTCCTGCTGTGCTTCG (forward) and CATC-
GGCAAGCTGAATTCTACTATAGACCCATCCTTGC (re-
verse) primers to generate a 59 HindIII and a 39 EcoRI restriction
site. The PCR product was then cloned into the pcDNA-RFP-C
vector (a gift of Roger Tsien, UCSD, USA) to generate a C-
terminal monomeric red fluorescent protein tag. All constructs
were verified by sequencing prior to use.
Western blotting and Immunoprecipitation
MCF7 and FLCARMCF7 cells were seeded on 10-cm plates in
DMEM with 10% FBS and left for 4 hours. They were then
washed twice with ice-cold phosphate-buffered saline (PBS) and
lysed with 50 ml of RIPA buffer (10 mM Tris (pH 7.4), 150 mM
Figure 4. E-cadherin is more dynamic within junctions in the presence of Ad5eGFP. (A) Example images from a FRAP experiment on MCF7
cells expressing E-cadherin-GFP. MCF7 were transiently transfected with E-cadherin-GFP for 24 hours before being plated on glass bottomed imaging
chambers. Images were captured, analysed and exported using NIS Elements AR software. An image was taken immediately after the bleach and one
5 seconds after that, and then images were taken every 15 seconds for 5 minutes. Images shown for pre-bleach, bleach (bleached region shown in
white box) and the recovery of E-cadherin-GFP monitored at 15 s, 30 s and 45 s post-bleach. (B) The half-life (t1/2) of E-cadherin recovery after
photobleaching MCF7 and FLCARMCF7 cells in the absence or presence of Ad5eGFP (MCF7+Ad5 and FLCARMCF7+Ad5 respectively). E-cadherin
recovery was defined from corrected intensity data fitted to a single exponential equation and calculated using the equation t1/2=ln 0.5/2t. Data
was pooled from .12 cells per condition over 4 independent experiments +/2 SEM. Significance was determined by two-way anova. **=p,0.001
compared to MCF7 cells no Ad5eGFP; *=p,0.05 compared to FLCARMCF7 no Ad5eGFP; *=p,0.05 compared to FLCARMCF7 with Ad5eGFP. (C)
Mobile and immobile E-cadherin fractions in MCF7 and FLCARMCF7 cells in the absence or presence of Ad5eGFP (MCF7+Ad5 and FLCARMACF7+Ad5
respectively). Mobile and immobile fractions were defined as the percentage recovery at plateau (mobile) and remaining non-recovered fraction at
this time (immobile fraction). Significance was determined by two-way anova. * *=P,0.001 *=P,0.05. (D) FACS analysis of cell surface E-cadherin
levels on MCF7 and FLCARMCF7 cells without (black bars) or with Ad5eGFP (9000 VP/cell; white bars). MFI is shown pooled from 3 independent
experiments +2/SEM. Significance was determined by a two-way anova. *=p,0.05 compared to MCF7 no Ad5eGFP levels.
doi:10.1371/journal.pone.0023056.g004
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e23056Figure 5. Ad5eGFP modulates CAR association with b-catenin. (A) (i) A mixed population of MCF7 and FLCARMCF7 cells were plated onto
vitronectin-coated coverslips and incubated with Ad5eGFP at 9000 VP/cell for 3 minutes and 10 minutes before fixation. Cells were then
immunostained for the .expression and localisation of E-cadherin (AB green) and b-catenin (AC; blue). Merged images are also shown (AD). Scale bars
are 20 mm. Representative images are shown from 3 independent experiments with similar results. (ii) Bar charts are quantitations of E-cadherin
intensity at junctions between FLCARRFP positive cells (FLCARMCF7), or those without CAR (MCF7) and calibrated on a per pixel basis to correct for
any differences in junction size/area. MCF7 junction intensity values were normalised to 1 and all values for FLCARMCF7 junctions represented as a
relative value to this. Values were pooled from multiple cells and images (n=.25 junctions per condition) over three independent experiments and
represented as relative mean intensity. p.0.05 for E-cadherin in FLCARMCF7 vs MCF7 at all time points. (B) Fluorescence images demonstrating
Ad5eGFP attachment to MCF7 and FLCARMCF7 cells. A mixed population of MCF7 and FLCARMCF7 cells were seeded onto vitronectin-coated
coverslips. Cells were incubated with Ad5eGFP-Cy5 (9000 VP/cell) for 3 minutes at 37uC before fixation with 4% PFA and imaged by confocal
microscopy. First two panels from left show FLCARMCF7 cells fixed and stained for CAR using RmcB (CAR-specific antibody) [1] followed by an Alexa
fluor 488-conjugated secondary antibody (first panel) and RFP. Third panel shows Ad5eGFP-Cy5 attachment to cells and fourth panel from left shows
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10 mM sodium fluoride, 1 mM okadaic acid with protease
inhibitor complex). The cell lysates were then scraped into
Eppendorf tubes and left on ice for 20 mins. Twenty micrograms
of lysate protein was loaded onto 10% polyacrylamide gels and
transferred to polyvinylidene difluoride membranes. Membranes
were blocked for 30 mins at room temperature in TBS-T (Sigma)
and 5% non-fat dry milk. Membranes were incubated with
primary antibodies at an appropriate dilution in TBS-T, overnight
at 4uC. The immunoblots were washed in TBS-T and incubated
for 2 hours with horseradish peroxidase-conjugated anti-mouse or
anti-rabbit immunoglobulin (Santa-Cruz Biotechnologies) at a
1:5000 dilution. Immunoblots were then washed with TBS-T and
visualized with ECL substrate reagent (Amersham Pharmacia).
Membranes were then stripped and re-probed for total protein.
Developed immunoblots were scanned in as tiff files and the
protein bands quantified by densitometry with ImageQuant
software. Bands of interest were normalised to the respective
loading controls and the average percentage change over control
(parental cells) levels quantified and plotted +/2 SEM.
Immunoprecipitation (IP) was performed by combining 1610
6
cell equivalents in total volume of 200 ml of RIPA buffer with
5m go fb-catenin antibody (Santa Cruz). The sample was then
mixed at 4uC. After mixing, 50 ml of A/G beads (Santa Cruz)
previously washed in 100 ml of PBS or lysis buffer 36were added
to the mixture and mixed at 4uC for 1 hour. The agarose beads
were pelleted, washed in PBS and then resuspended in
electrophoresis buffer. 25 ml of each sample was then run on a
10% PAGE gel. Gels were then subjected to Western Blotting and
ECL detection.
Cell adhesion assays
Reconstituted E-cadherin extra-cellular domain (R&D systems)
was diluted using DPBS (PBS containing Ca
2+) to a final
concentration of 1.5 mg/ml or 5 mg/ml. The E-cadherin protein
was then added to 4 wells of a 24-well plate at a volume of 400 ml/
well and incubated for 60 minutes at room temperature. To control
for non-specific adhesion control 300 ml of 1% BSA/PBS per well
was used and as a positive control for adhesion, vitronectin at
10 mg/ml per well was used. Plates were then incubated for
60 minutes at room temperature. After incubation, excess unbound
E-cadherin was removed and wells blocked with 300 ml/well 1%
BAS/PBS for 30 minutes at room temperature to prevent any non-
specific binding. MCF7 and FLCARMCF7 cells were disassociated
from their flasks using 1 mM EDTA and resuspended in serum free
media. Cells were then counted and 1610
5 cells added to each well
followed by incubation for 2 hours at 37uC. After incubation,
unbound cells were removed by washing with PBS. Adherent cells
were then trypsinised until all the bound cells had detached; they
were then counted using a haemocytometer.
Confocal microscopy
MCF7 and FLCARMCF7 cells were plated out on coverslips
and left to adhere. The cells were then washed with PBS and fixed.
Cells were permeabilised with 0.1% Triton X-100-TBS for
10 minutes at RT. Non-specific binding was blocked using 5%
BSA for 30 minutes at RT. 100 ml of each specified diluted
antibody was added to each of the coverslips and left at RT for
3 hours. Following this the coverslips were washed and then
incubated with goat anti-mouse Alexa Fluor 488 (Invitrogen). The
secondary antibody was left on the coverslips for 1 hour at room
temperature in the dark. The coverslips were washed once more
before being mounted onto microscope slides using FluorSave
TM
Reagent (calbiochem). Cells were viewed using the LSM 510
META confocal microscope (Carl Zeiss Ltd). Images shown are
single confocal slices unless otherwise stated.
Analysis of junctional protein intensity
Confocal images of mixed populations (1:1) of MCF7 and
FLCARMCF7 cells immunostained for different junctional
proteins were imported into Image J. Intensity levels of E-cadherin
or b-catenin were analysed in the same image at junctions between
FLCARRFP positive cells, or those without CAR and calibrated
on a per pixel basis to correct for any differences in junction size/
area. CAR-negative junction intensity values were normalised to 1
and all values for CAR positive junctions represented as a relative
value to this. Values were pooled from multiple cells and images
(n=.25 junctions per condition) over three independent
experiments and represented as relative mean intensity.
Cell permeability assay
MCF7 and FLCARMCF7 cells were grown to confluence on
polyester transwell-clear filters (0.4 mm pore size, 12 mm diame-
ter; Corning Costar Corporation). Ad5eGFP was added to the top
chamber two hours prior to FITC-dextran addition (1 mg/ml) or
simultaneously with fitc-dextran. 10 kD fitc-dextran (Sigma) was
added to the top well and allowed to equilibrate for 1 hour. The
fitc-dextran content of the lower chamber was then measured
using a fluorescence plate reader.
Fluorescence Recovery After Photobleaching (FRAP)
MCF7 and FLCARMCF7cells were transiently transfected in
24 well plates with E-cadherin-GFP or CAR-GFP for 24 hours
before being plated on glass bottomed imaging chambers and
maintained in growth media containing 25 mM Hepes. Confocal
microscopy FRAP experiments were performed on a Nikon A1R
microscope equipped with CFI Plan Fluor 406 oil objective.
Images were captured, analysed and exported using NIS Elements
AR software. Analysis of FRAP data was performed as described
by Worth et al [39]. At least 3 images were taken every 10 seconds
pre-bleach, and then a region of interest (ROI) was bleached
(464 mm ROI used for all experiments), for 20 iterations with the
bleach laser (488 nm) set at 100% and the pinhole at maximum.
An image was taken immediately after the bleach and one
5 seconds after that, and then images were taken every 15 seconds
for 5 minutes. Raw data was transferred to Excel and each cell
corrected for photo-fading (by correcting for the amount the whole
merged image indicating FLCARMCF7 cells to which Ad5eGFP–Cy5 was bound. Ad5eGFP-Cy5 faint binding to MCF7 cells is also shown in the third
and fourth panels. MCF7 cells in these panels are identified by lack of CAR or RFP expression. (C) (i) MCF7 and FLCARMCF7 cells were incubated with
Ad5eGFP (+Ad5) at 9000 VP/cell or FK (+FK) at 160 mg/ml for 3 min, 10 min or 6 hours. Cells were then lysed and immuno-precipitated with b-catenin
or control IgG followed by probing for E-cadherin. Blots were re-probed with b-catenin to control for loading and b-catenin re-probe of FK
experiment is shown as an example. (ii) Whole cell lysates used for the b-catenin IP, run on a separate gel and shown for presentation. (iii) Bar charts
showing mean densitometry quantification +/2 SEM from four independent experiments showing relative levels of the E-cadherin/b-catenin
complex for each Ad5 and FK treatments. (D) Blots as in experiments outlined in (B) re-probed for the presence of CAR. Bar chart is mean
densitometry quantification +/2 SEM from four independent experiments showing relative levels of CAR within the complex for Ad5 treatment.
Significance was determined by a one-way anova. *=P,0.05.
doi:10.1371/journal.pone.0023056.g005
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were converted into percentage values of the intensity pre-bleach.
Corrected intensity values were plotted over time and the intensity
at which the recovery curve plateau was defined. Mobile and
immobile fractions were defined as the percentage recovery at
plateau (mobile) and remaining non-recovered fraction at this time
(immobile fraction). The half-life (t1/2) of recovery was defined
from corrected intensity data fitted to a single exponential
equation and calculated using the equation t1/2=ln 0.5/2t. Data
was pooled from at least 12 cells over 4 independent experiments.
Statistical Analysis
All results were analysed for statistical significance using the
SigmaStat software. Significance was determined by conducting a
Two-Way or One-Way Anova where appropriate.
Supporting Information
Figure S1 Localisation of FLCARRFP in FLCARMCF7
cells. MCF7 cells were transfected with RFP-tagged full length
CAR (FLCARRFP). Confocal images taken in the red channel as
well as the phase contrast images are shown for FLCARMCF7 (A)
and parental MCF7 cells (B). FLCARRFP is shown at cell-cell
junctions as well as intracellular compartments.
(TIFF)
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